AtaiBeckley ATAI
NASDAQ ATAI
$7.40 +0.06 (+0.82%)
As of: Sep 4, 2026 · 3:16 PM EDT

AtaiBeckley (ATAI) Share-based Compensation (2020 - 2026)

AtaiBeckley (ATAI) posted Share-based Compensation of $21.4 million for Q3 2025, up 921.97% sequentially from $2.1 million in Q2 2025, and up 4180.0% YoY from $500000.0 in Q3 2024.

Analysis

AtaiBeckley (ATAI) Share-based Compensation (2020 - 2026) Analysis & Trends

AtaiBeckley's Share-based Compensation history runs 2 years deep, the most recent figure standing at $50.8 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 1414.16% year-over-year to $50.8 million; the TTM figure through Mar 2026 stood at $50.8 million (changed N/A YoY), while the FY2025 annual figure was $14.2 million, down 44.24% from the prior year.
  • Share-based Compensation improved to $21.4 million in Q3 2025 per ATAI's latest filing, from $2.1 million in the prior quarter.
  • The five-year high for Share-based Compensation was $50.8 million in Q1 2026, with the low at $3.4 million in Q1 2025.
  • A 5-year average of $6.5 million and a median of $6.0 million in 2024 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2024: Share-based Compensation slumped 99.38% in 2022, then soared 5750.47% in 2024.
  • Over 5 years, Share-based Compensation stood at $13.4 million in 2021, then declined by 9.39% to $12.1 million in 2022, then plunged by 39.83% to $7.3 million in 2023, then rose by 15.02% to $8.4 million in 2024, then soared by 154.7% to $21.4 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $21.4 million, $2.1 million, and $8.4 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 277.20 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 41.25 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn - 23.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.53 Mn
Mar 31, 2026 34.32 Mn
Dec 31, 2025 6.92 Mn
Sep 30, 2025 23.89 Mn
Jun 30, 2025 27.20 Mn
Jun 30, 2025 2.69 Mn
Mar 31, 2025 3.36 Mn
Mar 31, 2025 24.14 Mn
Dec 31, 2024 6.92 Mn
Dec 31, 2024 8.40 Mn
Sep 30, 2024 500,000.00
Jun 30, 2024 6.28 Mn
Mar 31, 2024 22.86 Mn
Dec 31, 2023 7.31 Mn
Sep 30, 2023 18.75 Mn
Jun 30, 2023 20.84 Mn
Mar 31, 2023 19.09 Mn
Dec 31, 2022 12.14 Mn
Sep 30, 2022 18.93 Mn
Jun 30, 2022 21.04 Mn